T. Johnson

Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results.

M. Suchard, M. Flechtner-Mors, H. Ditschuneit, 2000, Obesity research.

Risedronate Preserves Bone Architecture in Early Postmenopausal Women In 1 Year as Measured by Three-Dimensional Microcomputed Tomography

T. Dufresne, B. Borah, M. Manhart, 2003, Calcified Tissue International.

Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.

A. Chines, T. Dufresne, B. Borah, 2004, Bone.

Seven Years of Treatment with Risedronate in Women with Postmenopausal Osteoporosis

D. Mellström, C. Roux, A. Chines, 2004, Calcified Tissue International.

Five Years of Treatment with Risedronate and its Effects on Bone Safety in Women with Postmenopausal Osteoporosis

A. Chines, L. Ste-Marie, T. Johnson, 2004, Calcified Tissue International.

Risedronate, a Highly Effective, Short-Term Oral Treatment for Paget's Disease: A Dose-Response Study

J. Reginster, D. Hosking, P. Bekker, 1999, Calcified Tissue International.

Metabolic and weight-loss effects of a long-term dietary intervention in obese patients.

M. Flechtner-Mors, H. Ditschuneit, H. Ditschuneit, 1999, The American journal of clinical nutrition.

Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes

T. Rosenberg, H. Hill, Harry R Hill, 2012, Therapeutic advances in musculoskeletal disease.